Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma

Rizell, M; Eilard, MS; Andersson, M; Andersson, B; Karlsson-Parra, A; Suenaert, P

Suenaert, P (reprint author), Immunicum AB, Stockholm, Sweden.

FRONTIERS IN ONCOLOGY, 2019; 9 ():

Abstract

Several lines of evidence support immunotherapy in hepatocellular carcinoma (HCC). We have shown that intratumoral injections of the immune primer ili......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索